Yes. Augmentin tablets do not contain dairy ingredients, so a dairy-free diet does not affect absorption or efficacy.
A mild rash may be a common side effect, but any skin eruption that spreads, blisters, or is accompanied by fever should be reported promptly, as it could signal a severe allergic reaction.
Augmentin is a prescription-only medication in the UK. When traveling, carry the original prescription label, a copy of the prescription, and declare the medication at security if required.
Plain amoxicillin lacks clavulanate, so it is ineffective against bacteria that produce β-lactamase enzymes. Augmentin’s clavulanate component protects amoxicillin, broadening the spectrum to include β-lactamase-producing strains.
There is no known pharmacokinetic interaction between Augmentin and proton-pump inhibitors, so they can be co-administered.
Clavulanate can cause mild, reversible changes in urine colour due to metabolites. If the urine is dark and accompanied by other symptoms such as jaundice, seek medical advice.
Augmentin is not listed on any prohibited substance tables for sport. However, athletes should be aware of the risk of gastrointestinal upset that might affect training performance.
The 500 mg amoxicillin/125 mg clavulanate tablet is typically imprinted with “GL-500” on one side and “CLV-125” on the other, but markings can vary by batch.
Antacids containing aluminum or magnesium may slightly reduce the absorption of amoxicillin. To minimise this effect, space the dosing of antacids at least two hours apart from Augmentin.
Unused tablets should be discarded after the expiry date or within six months of opening the blister pack, whichever comes first. Do not store them beyond the recommended period for optimal potency.
Augmentin is a prescription-only antibiotic (POM) marketed in the United Kingdom by GlaxoSmithKline. It combines two active ingredients - amoxicillin and clavulanate potassium - in a single oral pill. The medication belongs to the antibiotics therapeutic class and is available in the following strengths:
Augmentin is indicated for a range of bacterial infections and must be prescribed by a qualified prescriber in England, Wales, Scotland, or Northern Ireland.
Augmentin’s antibacterial effect stems from the complementary actions of its two components:
Together, the combination achieves rapid bacterial killing and a broader range of activity than amoxicillin alone. Onset of action typically occurs within an hour after oral ingestion, with peak plasma concentrations reached in 1-2 hours. The drug’s half-life is about 1 hour for amoxicillin and 1.5 hours for clavulanate, requiring multiple daily doses to maintain effective levels.
Augmentin is approved by the UK Medicines and Healthcare products Regulatory Agency (MHRA) for the following infections:
The medication is prescribed for adults and children over 12 years of age, with pediatric dosing adjusted by weight.
Some clinicians prescribe Augmentin for conditions not listed on the product licence, based on published evidence:
Disclaimer: Off-label use requires careful risk-benefit assessment by a qualified healthcare provider and should not replace standard, approved therapy.
These effects are usually transient and can be mitigated by taking the medication with food.
The exact regimen depends on infection type, severity, and patient-specific factors.
This article provides educational information about Augmentin and is not a substitute for professional medical advice. Treatment decisions, including use for unapproved indications, must be made under the guidance of a qualified healthcare provider. The content is intended for informational purposes and does not constitute medical recommendations. Always consult a physician before starting, stopping, or changing any medication regimen.
